Abstract:Abstract Background Thymocyte-expressed, positive selection-associated 1 (Tespa1) is a critical signaling molecule in thymocyte development. This study aimed to investigate the regulatory effect of Tespa1 on mast cells in the pathogenesis of asthma and its relationship with the interleukin (IL)-4 /signal transducers and activators of transcription 6 (STAT6) signaling pathway. Methods Tespa1 mRNA expression analysis and IgE levels were carried out using the induced sputum of 33 adults with stable asthma and 36 healthy controls. Tespa1- knockout mice ( Tespa1 -/- , KO) and C57BL/6 background (wild-type, WT) mice were sensitized and treated with ovalbumin (OVA) to establish an asthma model. Pathological changes, number and activity of mast cells, and changes in activity of the IL-4 /STAT-6 pathway in lung tissue were detected. The changes of enzyme activity and STAT6 activity after mast cell gene knockout were analyzed in vitro . The changes of enzyme activity and STAT6 activity after mast cell gene knockout were analyzed in vitro . The association between the Tespa1 and P-STAT6 was analyzed by immunoprecipitation method. Results Compared with the healthy controls, Tespa1 expression was decreased, and IgE levels were elevated in the sputum of asthmatic patients. Animal experiments showed that Tespa1 -/- mice exhibited more severe inflammation, higher quantity of goblet cells and mast cells in the bronchium, and greater activity of mast cell tryptase, which is induced by ovalbumin, than WT mice. And IL-4, IL-13, phospho-Janus kinase 1, and P-STAT6 expressions presented a higher increase in the Tespa1 -/- mouse model than in the WT mouse model. Further in vitro studies confirmed that IL-4 could more significantly promote tryptase and P-STAT6 activities in Tespa1 -/- mast cells than their WT counterparts. Correlation analysis results showed a negative correlation between Tespa1 and P-STAT6. Immunoprecipitation results showed a direct link between Tespa1 and P-STAT6. Conclusions Altogether, our results indicate that Tespa1 can negatively regulate mast cell activity, and this event is related to the mast cell IL-4/STAT6 signaling pathway and could be therapeutically exploited to treat asthma attacks.

The Escherichia coli heat-labile enterotoxin B subunit protects from allergic airway disease development by inducing CD4+ regulatory T cells

Eosinophils from Murine Lamina Propria Induce Differentiation of Naïve T Cells into Regulatory T Cells Via TGF-β1 and Retinoic Acid

Protection against allergic airway inflammation during the chronic and acute phases of Trichinella spiralis infection

Tespa1 negatively modulates asthmatic attack is associated with IL-4/STAT-6 pathway of mast cell

Ovalbumin-Induced Airway Inflammation Is Ameliorated in Dectin-1-Deficient Mice, in Which Pulmonary Regulatory T Cells Are Expanded through Modification of Intestinal Commensal Bacteria

Similar immune mechanisms control experimental airway eosinophilia elicited by different allergens and treatment protocols

Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation

Epicutaneous Antigen Exposure Induces A Th17 Response That Drives Airway Inflammation After Inhalation Challenge

Intestinal helminths protect in a murine model of asthma

IL-17 is selectively induced by epicutaneous sensitization and mediates neutrophil recruitment to the lungs following antigen challenge

TLR2 deficiency promotes IgE and inhibits IgG1 class-switching following ovalbumin sensitization

CD137 deficiency does not affect development of airway inflammation or respiratory tolerance induction in murine models

Deficiency of leukotriene B4 receptor type 1 ameliorates ovalbumin-induced allergic enteritis in mice

Effector TH17 Cells Give Rise to Long-Lived TRM Cells that Are Essential for an Immediate Response against Bacterial Infection

Suppression of type 2 immunity and allergic airway inflammation by secreted products of the helminth Heligmosomoides polygyrus

Control of Asthma and Allergy by Regulatory T Cells

In vitro-induced Foxp3+ CD8+ regulatory T cells suppress allergic IgE response in the gut

Ezh2 controls development of natural killer T cells, which cause spontaneous asthma-like pathology

Toxoplasma gondii Infection Induces Suppression in a Mouse Model of Allergic Airway Inflammation

Ablation of CD226 on CD4 + T cells modulates asthma progress associated with altered IL-10 response and gut microbiota

Eosinophils Contribute to Oral Tolerance via Induction of RORγt-Positive Antigen-Presenting Cells and RORγt-Positive Regulatory T Cells